Your browser doesn't support javascript.
loading
Rapidly accelerated development of neutralizing COVID-19 antibodies by reducing cell line and CMC development timelines.
Tan, Kee Wee; Ji, Pengfei; Qian, Zichen; Gao, Qiao; Wang, Shuai; Li, Qin; Gu, Mingzhu; Zhang, Qi; Hou, Chengjian; Huang, Yang; Lian, Dujuan; Wang, Junghao; Zhang, Zheng; Zhang, Sam; Wu, Jiansheng; Zhou, Weichang.
Afiliação
  • Tan KW; WuXi Biologics, Waigaoqiao Free Trade Zone, Shanghai, China.
  • Ji P; WuXi Biologics, Waigaoqiao Free Trade Zone, Shanghai, China.
  • Qian Z; WuXi Biologics, Waigaoqiao Free Trade Zone, Shanghai, China.
  • Gao Q; WuXi Biologics, Waigaoqiao Free Trade Zone, Shanghai, China.
  • Wang S; WuXi Biologics, Waigaoqiao Free Trade Zone, Shanghai, China.
  • Li Q; WuXi Biologics, Waigaoqiao Free Trade Zone, Shanghai, China.
  • Gu M; WuXi Biologics, Waigaoqiao Free Trade Zone, Shanghai, China.
  • Zhang Q; WuXi Biologics, Waigaoqiao Free Trade Zone, Shanghai, China.
  • Hou C; WuXi Biologics, Waigaoqiao Free Trade Zone, Shanghai, China.
  • Huang Y; WuXi Biologics, Waigaoqiao Free Trade Zone, Shanghai, China.
  • Lian D; WuXi Biologics, Waigaoqiao Free Trade Zone, Shanghai, China.
  • Wang J; WuXi Biologics, Waigaoqiao Free Trade Zone, Shanghai, China.
  • Zhang Z; WuXi Biologics, Waigaoqiao Free Trade Zone, Shanghai, China.
  • Zhang S; WuXi Biologics, Waigaoqiao Free Trade Zone, Shanghai, China.
  • Wu J; WuXi Biologics, Waigaoqiao Free Trade Zone, Shanghai, China.
  • Zhou W; WuXi Biologics, Waigaoqiao Free Trade Zone, Shanghai, China.
Biotechnol Bioeng ; 2022 Dec 08.
Article em En | MEDLINE | ID: mdl-36482495

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Biotechnol Bioeng Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Biotechnol Bioeng Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China